Methods for treating and/or preventing diffuse alveolar hemorrhage

The present invention relates to methods for treating and/or preventing diffuse alveolar hemorrhage. In one aspect, the invention provides a method of inhibiting the effect of MASP-2-dependent complement activation in a human subject suffering from graft versus host disease and/or diffuse alveolar h...

Full description

Saved in:
Bibliographic Details
Main Authors SCHWAEBLE HANS-WERNER, DUDLER THOMAS, DEMOPULOS, GREGORY, A
Format Patent
LanguageChinese
English
Published 06.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to methods for treating and/or preventing diffuse alveolar hemorrhage. In one aspect, the invention provides a method of inhibiting the effect of MASP-2-dependent complement activation in a human subject suffering from graft versus host disease and/or diffuse alveolar hemorrhage and/or venous occlusion disease associated with hematopoietic stem cell transplantation. The method comprises the step of administering to a subject in need thereof an amount of a MASP-2 inhibitor effective to inhibit MASP-2-dependent complement activation. 本发明涉及用于治疗和/或预防弥漫性肺泡出血的方法。在一个方面,本发明提供在患有与造血干细胞移植有关的移植物抗宿主病和/或弥漫性肺泡出血和/或静脉闭塞性病的人受试者中抑制MASP-2-依赖性补体活化的作用的方法。所述方法包括给予有需要的受试者有效抑制MASP-2-依赖性补体活化的量的MASP-2抑制剂的步骤。
Bibliography:Application Number: CN202410427006